Clinical trial
Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment…
NCT00080028 · Pharmacyclics LLC., Industry · Terminated
Key facts
| NCT number | NCT00080028 |
|---|---|
| Title | Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer |
| Official title | Phase I Trial of Motexafin Gadolinium and Chemoradiation in Locally Advanced, Squamous Cell Carcinoma of the Head and Neck |
| Lead sponsor | Pharmacyclics LLC., Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer, Oropharynx Cancer, Larynx Cancer, Hypopharynx Cancer |
| Intervention type | Drug |
| Interventions | Motexafin Gadolinium Injection |
| Enrollment | 18 |
| First posted | Mar 23, 2004 |
| Last update posted | May 8, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: